stachydrine has been researched along with Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Cheng, F; Guo, C; Peng, C; Wang, M; Zhang, R; Zhou, Y | 1 |
| Guan, YF; Lu, Y; Tong, QQ; Wang, SJ; Xing, ZH; Zhang, C; Zhang, L | 1 |
1 review(s) available for stachydrine and Fibrosis
| Article | Year |
|---|---|
A review of pharmacological and pharmacokinetic properties of stachydrine.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cardiotonic Agents; Female; Fibrosis; Humans; Neuroprotective Agents; Proline; Uterus | 2020 |
1 other study(ies) available for stachydrine and Fibrosis
| Article | Year |
|---|---|
Effect of stachydrine on endoplasmic reticulum stress-induced apoptosis in rat kidney after unilateral ureteral obstruction.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Caspase 3; Creatinine; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Fibrosis; Kidney; Kidney Diseases; Male; Molecular Structure; Proline; Rats; Rats, Wistar; Transcription Factor CHOP; Ureteral Obstruction | 2013 |